These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 19448681)

  • 41. Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia.
    Tauro S; Craddock C; Peggs K; Begum G; Mahendra P; Cook G; Marsh J; Milligan D; Goldstone A; Hunter A; Khwaja A; Chopra R; Littlewood T; Peniket A; Parker A; Jackson G; Hale G; Cook M; Russell N; Mackinnon S
    J Clin Oncol; 2005 Dec; 23(36):9387-93. PubMed ID: 16314618
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HLA-matched allo-SCT after reduced intensity conditioning with fludarabine/CY in patients with metastatic breast cancer.
    Fleskens AJ; Lalisang RI; Bos GM; van Gelder M; Jansen RL; Schouten HC
    Bone Marrow Transplant; 2010 Mar; 45(3):464-7. PubMed ID: 19633692
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors.
    Ueno NT; Cheng YC; Rondón G; Tannir NM; Gajewski JL; Couriel DR; Hosing C; de Lima MJ; Anderlini P; Khouri IF; Booser DJ; Hortobagyi GN; Pagliaro LC; Jonasch E; Giralt SA; Champlin RE
    Blood; 2003 Nov; 102(10):3829-36. PubMed ID: 12881308
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer.
    Ueno NT; Rondón G; Mirza NQ; Geisler DK; Anderlini P; Giralt SA; Andersson BS; Claxton DF; Gajewski JL; Khouri IF; Körbling M; Mehra RC; Przepiorka D; Rahman Z; Samuels BI; van Besien K; Hortobagyi GN; Champlin RE
    J Clin Oncol; 1998 Mar; 16(3):986-93. PubMed ID: 9508181
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Allogeneic stem-cell transplantation of renal cell cancer after nonmyeloablative chemotherapy: feasibility, engraftment, and clinical results.
    Rini BI; Zimmerman T; Stadler WM; Gajewski TF; Vogelzang NJ
    J Clin Oncol; 2002 Apr; 20(8):2017-24. PubMed ID: 11956260
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nonmyeloablative allogeneic blood stem cell transplantation in patients with metastatic solid tumors.
    Busca A; Novarino A; de Fabritiis P; Picardi A; Zeuli M; Locatelli F; Bertetto O; Falda M
    Hematology; 2006 Jun; 11(3):171-7. PubMed ID: 17325957
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Successful nonmyeloablative allogeneic stem cell transplantation for therapy-related acute myelogenous leukemia in a patient with preexisting visceral fungal infection.
    Ostronoff F; Ostronoff M; Calixto R; Maior AP; Sucupira A; Florêncio R; Domingues M
    J Pediatr Hematol Oncol; 2011 Jan; 33(1):62-4. PubMed ID: 20463605
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduced intensity conditioning for allograft after cytoreductive autograft in metastatic breast cancer.
    Carella AM; Beltrami G; Corsetti MT; Nati S; Musto P; Scalzulli P; Gonella R; Ballestrero A; Patrone F
    Lancet; 2005 Jul 23-29; 366(9482):318-20. PubMed ID: 16039336
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is there a role for dose-intensive chemotherapy with stem cell rescue in breast cancer?
    Williams SF
    Oncology (Williston Park); 2002 Dec; 16(12):1643-6, 1649; discussion 1650, 1655-6. PubMed ID: 12520640
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nonmyeloablative allogeneic hematopoietic stem cell transplantation for metastatic breast cancer.
    Bishop MR
    Clin Breast Cancer; 2003 Apr; 4(1):39-45. PubMed ID: 12744757
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High-dose chemotherapy and allogeneic immunotherapy.
    Childs R; Srinivasan R
    Lancet; 2005 Jul 23-29; 366(9482):273-5. PubMed ID: 16039317
    [No Abstract]   [Full Text] [Related]  

  • 52. Graft-vs-tumor effect in patients with advanced nasopharyngeal cancer treated with nonmyeloablative allogeneic PBSC transplantation.
    Toh HC; Chia WK; Sun L; Thng CH; Soe Y; Phoon YP; Yap SP; Lim WT; Tai WM; Hee SW; Tan SH; Leong SS; Tan EH
    Bone Marrow Transplant; 2011 Apr; 46(4):573-9. PubMed ID: 20661236
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer.
    Bregni M; Dodero A; Peccatori J; Pescarollo A; Bernardi M; Sassi I; Voena C; Zaniboni A; Bordignon C; Corradini P
    Blood; 2002 Jun; 99(11):4234-6. PubMed ID: 12010834
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Modern principles of chemotherapy of metastatic breast cancer].
    Syvak LA; Maĭdanevych NM; Lial'kin SA; Askolskyĭ AV; Alpat'ieva SIu; Bagirian MA; Klimanov MIu; Kasap NV
    Lik Sprava; 2011; (1-2):70-5. PubMed ID: 21954638
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduced-intensity allogeneic transplantation for lymphoma.
    Kogel KE; McSweeney PA
    Curr Opin Oncol; 2002 Sep; 14(5):475-83. PubMed ID: 12192265
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Profound graft-versus-tumor response in metastatic breast cancer with nonmyeloablative allografting.
    Carella AM; Ferrara R; Orcioni GF; Pepe G; Villavecchia G
    Ann Oncol; 2007 Oct; 18(10):1751-4. PubMed ID: 17890219
    [No Abstract]   [Full Text] [Related]  

  • 57. Thalidomide-induced perioral neuropathy.
    Elad S; Galili D; Garfunkel AA; Or R
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Oct; 84(4):362-4. PubMed ID: 9347498
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nonmyeloablative allogeneic stem cell transplantation for nasopharyngeal carcinoma.
    Chia WK; Wang WW; Lim WT; Tai WM; Sun L; Thng CH; Soe Y; Yap SP; Tan EH; Toh HC
    Oncologist; 2010; 15(11):1192-7. PubMed ID: 20980417
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of the anti-idiotype breast cancer vaccine 11D10 in conjunction with autologous stem cell transplantation in patients with metastatic breast cancer.
    Reece DE; Foon KA; Bhattarcharya-Chatterjee M; Adkins D; Broun ER; Connaghan DG; Dipersio JF; Holland HK; Howard DA; Hale GA; Klingemann HG; Munn RK; Raptis A; Phillips GL
    Clin Breast Cancer; 2003 Feb; 3 Suppl 4():S152-7. PubMed ID: 12620153
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fludarabine downregulates indoleamine 2,3-dioxygenase in tumors via a proteasome-mediated degradation mechanism.
    Hanafi LA; Gauchat D; Godin-Ethier J; Possamaï D; Duvignaud JB; Leclerc D; Grandvaux N; Lapointe R
    PLoS One; 2014; 9(6):e99211. PubMed ID: 24911872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.